Bozena Jaentschke Centre for Vaccine Evaluation, Biologics and Genetic Therapies Directorate, HPFB Health canada Biography Publications Institution JoVE Articles Bozena Jaentschke has not added a biography. If you are Bozena Jaentschke and would like to personalize this page please email our Author Liaison for assistance. Publications Qualitative Und Quantitative Analysen Der Praktisch Alle Subtypen Der Grippe A Und B Virale Neuraminidasen Unter Verwendung Der Antikörper, Die Gezielt Der Universell Konservierten Sequenzen Vaccine. Aug, 2010 | Pubmed ID: 20621113 Eine Einfache Steckplatz Fleck Zum Nachweis Von Nahezu Alle Untertypen Von Der Grippe A Viral Hemagglutinins Mit Universal Antikörper, Die Gezielt Des Fusion-Peptids Nature Protocols. 2010 | Pubmed ID: 20010723 SARS-Coronavirus: Ungewöhnliche Labilität Des Nukleokapsid-Proteins Biochemical and Biophysical Research Communications. Dec, 2008 | Pubmed ID: 18926799 Zytotoxische Dosen Von Ketoconazol Beeinflussen Ausdruck Einer Teilmenge Der Leber Gene Journal of Toxicology and Environmental Health. Part A. Nov, 2007 | Pubmed ID: 17966066 Quantitative Analysen aller Influenza Typ A Viral Hämagglutininen und Neuraminidasen mit Universal Antikörper in Einfache Slot Blot Assays Caroline Gravel*1, Changgui Li*2, Junzhi Wang2, Anwar M Hashem1,3,4, Bozena Jaentschke1, Gary Van Domselaar5, Runtao He5, Xuguang Li1,3 1Centre for Vaccine Evaluation, Biologics and Genetic Therapies Directorate, HPFB, Health canada, 2National Institute for the Control of Pharmaceutical and Biological Products, The State Food and Drug Administration, Beijing, 3Department of Biochemistry, Microbiology and Immunology, University of Ottawa, 4Microbiology Department, Faculty of Medicine, King Abdulaziz University, 5National Microbiology Laboratory, Public Health Agency of Canada JoVE 2784 Immunology and Infection
Quantitative Analysen aller Influenza Typ A Viral Hämagglutininen und Neuraminidasen mit Universal Antikörper in Einfache Slot Blot Assays Caroline Gravel*1, Changgui Li*2, Junzhi Wang2, Anwar M Hashem1,3,4, Bozena Jaentschke1, Gary Van Domselaar5, Runtao He5, Xuguang Li1,3 1Centre for Vaccine Evaluation, Biologics and Genetic Therapies Directorate, HPFB, Health canada, 2National Institute for the Control of Pharmaceutical and Biological Products, The State Food and Drug Administration, Beijing, 3Department of Biochemistry, Microbiology and Immunology, University of Ottawa, 4Microbiology Department, Faculty of Medicine, King Abdulaziz University, 5National Microbiology Laboratory, Public Health Agency of Canada JoVE 2784 Immunology and Infection